Skip to main content
TipRanks
Go Ultimate75% OFF

3D Medicines, Inc. (1244) Income Statement

3 Followers

3D Medicines, Inc. Income Statement

Last quarter (Q2 2026), 3D Medicines, Inc.'s total revenue was ¥210.75M, an increase of 2.10% from the same quarter last year. In Q2, 3D Medicines, Inc.'s net income was ¥-85.32M. See 3D Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 356.09M¥ 445.65M¥ 634.95M¥ 567.39M¥ 60.26M
¥ 298.97M¥ 371.74M¥ 524.01M¥ 525.18M¥ 55.98M
¥ 411.62M¥ 495.17M¥ 1.02B¥ 846.54M¥ 559.07M
Depreciation and Amortization¥ 15.16M¥ 25.25M¥ 25.46M¥ 21.60M¥ 12.59M
¥ -191.18M¥ -209.56M¥ -529.23M¥ -1.03B¥ -1.45B
¥ -112.65M¥ -123.43M¥ -497.25M¥ -386.17M¥ -516.25M
¥ -72.29M¥ -75.95M¥ -65.22M¥ -665.86M¥ -945.57M
¥ -184.94M¥ -199.38M¥ -562.47M¥ -1.05B¥ -1.46B
¥ -177.53M¥ -182.66M¥ -524.70M¥ -1.02B¥ -1.43B
Per Share Metrics
Basic EPS¥ -0.72¥ -0.75¥ -2.30¥ -22.52¥ -36.72
Diluted EPS¥ -0.72¥ -0.75¥ -2.30¥ -22.52¥ -36.72
Weighted Average Shares Outstanding245.49M244.96M228.47M45.49M39.05M
Weighted Average Shares Outstanding (Diluted)245.49M244.96M228.47M45.49M39.05M

Currency in CNY

3D Medicines, Inc. Earnings and Revenue History

-1.6B-800M0800M-3000 %-2000 %-1000 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin